Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

Ruan, Jia, Martin, Peter, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Furman, Richard R., Christos, Paul, Rodriguez, Amelyn, Svoboda, Jakub, Lewis, Jessica, Katz, Orel, Coleman, Morton, Leonard, John P.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1505237

Cited by (236)

Items 101–200 of 236

Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment
Takashi Watanabe · 2021 · Cancers
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
Samuel Yamshon, Gui Zhen Chen, Caitlin K. Gribbin, Paul J. Christos, Bijal Dinesh Shah, Stephen J. Schuster, Sonali M. Smith, Jakub Svoboda, Richard R. Furman, John Paul Leonard et al. · 2023 · Blood Advances
Rational therapeutic choice for older patients with lymphoma
D Bron, Pierre Soubeyran · 2017 · Current Opinion in Oncology
Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma
Jeff D. Wang, Samuel G. Katz, Elizabeth A. Morgan, David T. Yang, Xueliang Jeff Pan, Mina L. Xu · 2019 · Human Pathology
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma
Sumita Ratnasingam, Joshua M. L. Casan, Jake Shortt, Eliza Anne Hawkes, Michael Gilbertson, Zoe McQuilten, George Grigoriadis, Kay Htun, Su Myat Htet, Philip J. Campbell et al. · 2019 · Scientific Reports
Watch and Wait in Mantle Cell Lymphoma
Christina Y. Lee, Peter Martin · 2020 · Hematology/Oncology Clinics of North America
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
Mengyang Di, Can Cui, Shalin K. Kothari, Amer Methqal Zeidan, Nikolai Alexandrovich Podoltsev, Natalia Neparidze, Rory Michael Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington · 2022 · Blood Advances
Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
Erden Atilla, Pınar Ataca Atilla, Taner Demirer · 2016 · International Journal of Hematology
The evolving role of targeted biological agents in the management of indolent B-cell lymphomas
Trent Peng Wang, John Harwood Scott, Stefan Klaus Barta · 2017 · Therapeutic Advances in Hematology
Simplified MIPI-B prognostic stratification method can predict the outcome well—retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China
Jingsong He, Xi Chen, Guoqing Wei, Jie Sun, Weiyan Zheng, Jimin Shi, Wen-Jun Wu, Yi Zhao, Gaofeng Zheng, He Huang et al. · 2019 · Medicine
Mantle Cell Lymphoma
Benjamin T. Diamond, Anita Ashok Kumar · 2019 · Hematology/Oncology Clinics of North America
Affinity-Based Polymers Provide Long-Term Immunotherapeutic Drug Delivery Across Particle Size Ranges Optimal for Macrophage Targeting
Nathan Andrew Rohner, Linda N. Purdue, Horst A. von Recum · 2020 · Journal of Pharmaceutical Sciences
Treatment of the elderly patient with mantle cell lymphoma
Pierre Soubeyran, Rémy Gressin · 2016 · Hematology
Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort study
Satoshi Dote, Kaori Ito, Shoji Itakura, Takeo Yasu, Daiki Hira, Satoshi Noda, Shigeki Yamada, Yuka Kobayashi, Tomohiro Terada · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL
Simon Husby, Cecilie Bæch‐Laursen, Christian Winther Eskelund, Francesco Favero, Jakob Schmidt Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten Utoft Niemann, Joachim Weischenfeldt, Riikka Räty et al. · 2022 · Leukemia
Advancements in B‐Cell Non‐Hodgkin’s Lymphoma: From Signaling Pathways to Targeted Therapies
Abdullah Alfaifi, Salem Bahashwan, Mohammed Alsaadi, Ali H Ageel, Hamzah H. Ahmed, Kaneez Fatima, Hafiz Mosa Malhan, Ishtiaq Qadri, Hussein A. Almehdar · 2024 · Advances in Hematology
Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells
Danielle S. Wallace, Patrick Michael Reagan · 2021 · Drugs
Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy
Jia Ruan, Peter Martin · 2016 · Current Hematologic Malignancy Reports
Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies
David Augustus Qualls, Anita Ashok Kumar, Zachary Drew Epstein-Peterson · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Novel treatment for mantle cell lymphoma – impact of BTK inhibitors and beyond
Caitlin K. Gribbin, Jane Chen, Peter Martin, Jia Ruan · 2023 · Leukemia & lymphoma/Leukemia and lymphoma
Novel agents in mantle cell lymphoma
David L. Tucker, Simon A. Rule · 2017 · Expert Review of Anticancer Therapy
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
Haige Ye, Aakash P. Desai, Shengjian Huang, Dayoung Jung, Richard E. Champlin, Dongfeng Zeng, Fangfang Yan, Krystle J. Nomie, Jorge Enrique Romaguera, Makhdum Ahmed et al. · 2018 · Journal of Experimental & Clinical Cancer Research
Clinical experience with lenalidomide alone or in combination with rituximab in indolent B-cell and mantle cell lymphomas
Jia Ruan, Bijal Dinesh Shah, Peter Martin, Stephen J. Schuster · 2016 · Annals of Oncology
Combination therapy with the type II anti-CD20 antibody obinutuzumab
Christian Klein, Marina Bacac, Pablo Umaña, Günter Fingerle‐Rowson · 2017 · Expert Opinion on Investigational Drugs
Treatment of mantle cell lymphoma in older adults
Daniel Fellows Pease, Vicki A. Morrison · 2018 · Journal of Geriatric Oncology
Mantle Cell Lymphoma: Which Patients Should We Transplant?
James Nathan Gerson, Stefan Klaus Barta · 2019 · Current Hematologic Malignancy Reports
Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma
Tomiyuki Sugi, Yasuo Nishigami, Saigo Hirohisa, Homare Hanai, Takabatake Keisuke, Mitsuo Mita, Shin Ohara, Shiro Ide, Tomoyuki Uchida, Morihiro Inoue et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
Novel synthetic drugs for the treatment of non-Hodgkin lymphoma
Farheen Manji, Robert Puckrin, Douglas Allan Stewart · 2021 · Expert Opinion on Pharmacotherapy
Designing Single-Arm Clinical Trials: Principles, Applications, and Methodological Considerations
Shuna Yao, Qingyao Shang, Meishuo Ouyang, Heng Zhou, Zhihua Yao, Yanyan Liu, Sheng Luo · 2025 · Annals of Clinical Epidemiology
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma
Jia Ruan, David Alan Bond, Bijal Dinesh Shah, John Nathan Allan, Sarah C. Rutherford, Caitlin K. Gribbin, Zhengming Chen, Bhavneet Bhinder, Wayne Tam, Davide Rossi et al. · 2025 · Blood Advances
Frontline therapy and role of high-dose consolidation in mantle cell lymphoma
Simon A. Rule · 2016 · Hematology
Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma
Brian G. Till · 2018 · Current Treatment Options in Oncology
Management of Older Adults with Mantle Cell Lymphoma
Jason T. Romancik, Jonathon Brett Cohen · 2020 · Drugs & Aging
Approach to the Initial Treatment of Older Patients with Mantle Cell Lymphoma
Jia Ruan · 2020 · Hematology/Oncology Clinics of North America
Mantle cell lymphoma: insights into therapeutic targets at the preclinical level
Pavel Klener · 2020 · Expert Opinion on Therapeutic Targets
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
Neerav Monga, Jamie Garside, Matthew Steven Davids, Constantine Si Lun Tam, Katherine Ward, Iain Fotheringham, Peter O’Donovan, Lori Parisi, Christoph Tapprich · 2020 · PharmacoEconomics - Open
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
Meng Chieh Wu, Yun Li, Huiqiang Huang, Wei Xu, Yanyan Wang, Haiwen Huang, Weili Zhao, Shuo Liu, Pengpeng Xu, Zhengming Chen et al. · 2022 · Frontiers in Oncology
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
Jacob Drobnyk Soumerai, Matthew Steven Davids, Lillian L. Werner, David Christopher Fisher, Philippe A. Armand, Philip C. Amrein, Donna S Neuberg, Ephraim P. Hochberg, Jennifer R. Brown, Jeremy S. Abramson · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents
Michael J. Buege, Anita Ashok Kumar, Brianne N. Dixon, Laura A. Tang, Terry Pak, Jennifer Orozco, Tim J. Peterson, Kathryn T. Maples · 2020 · Annals of Pharmacotherapy
Lenalidomide plus Rituximab for Mantle-Cell Lymphoma
Kenji Tsuda, Tetsuya Tanimoto, Tsunehiko Komatsu · 2016 · New England Journal of Medicine
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long‐term follow‐up of the Nordic Lymphoma Group MCL6 Philemon trial
Elin Forsgren, Rasmus Rask Kragh Jørgensen, Hans Bentzen, Jon Riise, Jacob Haaber, Annika Pasanen, Hanne K. Kuitunen, Karin Fahl Wader, Tarec Christoffer El‐Galaly, Martin Hutchings et al. · 2025 · HemaSphere
Mantle Cell Lymphoma
Andre Henri Goy · 2016 · Hematology/Oncology Clinics of North America
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells
Elia Boccellato, Lorenzo Comba, Rita Tavarozzi, Claudia Castellino, Myriam Foglietta, Daniele Giovanni Mattei, Marco Ladetto, Massimo Massaia, Alessia Castellino · 2025 · Cancers
Therapeutic antibodies for mantle cell lymphoma: A brand-new era ahead
Ming Sun, Han Zhang · 2019 · Heliyon
Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma
Titas Banerjee, Anusha Vallurupalli · 2021 · Current Problems in Cancer
Application of a double-colour upconversion nanofluorescent probe for targeted imaging of mantle cell lymphoma
Guang Y. Yang, Yong Bing Cao, Bin Yan, Qiang Lv, Jianbo Yu, Fusheng Zhao, Zhihong Chen, Heran Yang, Mengxi Chen, Zaishun Jin · 2017 · Oncotarget
SOHO State of the Art Updates and Next Questions: Managing Relapsed Mantle Cell Lymphoma
Jason T. Romancik, Drew G. Gerber, Tony Zhuang, Jonathon Brett Cohen · 2022 · Clinical Lymphoma Myeloma & Leukemia
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
Zachary Drew Epstein-Peterson, Esther N Drill, Umut Aypar, Connie Lee Batlevi, Philip C. Caron, Ahmet Doǧan, Pamela R. Drullinsky, John F. Gerecitano, Paul A. Hamlin, Caleb Ho et al. · 2023 · Haematologica
Evolving treatment strategies in mantle cell lymphoma
Natasha Catherine Edwin, Brad S. Kahl · 2018 · Best Practice & Research Clinical Haematology
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
Yu‐Hung Wang, Shan‐Chi Yu, Bor‐Sheng Ko, Yi‐Tsung Yang, Ming Yao, Jih‐Luh Tang, Tai‐Chung Huang · 2020 · International Journal of Hematology
The safety of available chemo-free treatments for mantle cell lymphoma
Anna Korycka, Dariusz Wołowiec, Tadeusz Robak · 2020 · Expert Opinion on Drug Safety
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma
Zachary Drew Epstein-Peterson, Maria Lia Palomba · 2024 · Hematology
Sequencing of Novel Therapies for Mantle Cell Lymphoma
Jason T. Romancik, Jonathon Brett Cohen · 2021 · Current Treatment Options in Oncology
Maintenance regimen of GM‐CSF with rituximab and lenalidomide improves survival in high‐risk B‐cell lymphoma by modulating natural killer cells
Shunrong Sun, Wulipan Fulati, Lin Shen, Min Wu, Zilan Huang, Wensi Qian, Pingping Chen, Yingwei Hu, Mingyue Chen, Yu Xu et al. · 2023 · Cancer Medicine
Post-autologous transplant maintenance therapies in lymphoma: current state and future directions
Peter A. Riedell, Michael Russell Bishop · 2017 · Bone Marrow Transplantation
[The guideline of the diagnosis and treatment of mantle cell lymphoma in China (2022)].
2022 · PubMed Central
Challenges of treating mantle cell lymphoma in older adults
Javier L Munoz, Mazie Tsang, Yucai Wang, Tycel Jovelle Phillips · 2024 · Leukemia & lymphoma/Leukemia and lymphoma
Venous thromboembolism in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with lenalidomide: a systematic review
Marc Sorigué, Elisa Orna, Juan‐Manuel Sancho · 2018 · Leukemia & lymphoma/Leukemia and lymphoma
Impact of Pharmaceutical Product Quality on Clinical Efficacy
Vandana Soni, Vikas Pandey, Saket Asati, Rakesh Kumar Tekade · 2018 · Elsevier eBooks
Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?
Jason T. Romancik, Jonathon Brett Cohen · 2020 · Hematology/Oncology Clinics of North America
Blastoid variant of mantle cell lymphoma in palatine tonsil
Vítor Bonetti Valente, Tamara Fernandes De Castro, Aline Satie Takamiya, Renata Callestini, José Cândido Caldeira Xavier‐Júnior, Gabriel Macedo Cortopassi, Sebastião Conrado Neto, Francisco Urbano Collado, Éder Ricardo Biasoli, Glauco Issamu Miyahara et al. · 2021 · Oral Oncology
SOHO State of the Art Updates and Next Questions: Tailoring Upfront Therapy in Mantle Cell Lymphoma
Dilan Anil Patel, Brad S. Kahl · 2023 · Clinical Lymphoma Myeloma & Leukemia
Targeted Therapies in the Treatment of Mantle Cell Lymphoma
Colin J Thomas, Veronica Carvajal, Stefan Klaus Barta · 2024 · Cancers
Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report
Joana Marques, Fátima Ferreira, Daniel Melo, Margarida Santos, R. Vaz · 2020 · Head and Neck Pathology
Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation
John R Jones, Charlotte Pawlyn, Graham Hunter Jackson · 2021 · Expert Opinion on Drug Safety
Marginal Zone Lymphoma: Saudi Lymphoma Group’s Clinical Practice Guidelines for Diagnosis, Management and Follow-up
Magdy S. Kandil, Hani Alhashmi, Musa Fares Alzahrani, Ayman Alhejazi, Ibraheem Motabi, Reyad Dada, Mubarak M. Al-Mansour, Ahmed Sagheir · 2019 · Saudi Journal of Medicine and Medical Sciences
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
Lavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, Martin Hutchings, Riikka Räty, Mats Jerkeman, Sara Ek · 2020 · BMC Cancer
B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma
Francesca Maria Quaglia, Simona Gambino, Marilisa Galasso, Maria Carmela Vegliante, Carlo Visco, Maria Teresa Scupoli · 2025 · Cell Communication and Signaling
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?
Rory McCulloch, Toby Andrew Eyre, Simon A. Rule · 2020 · Hematology/Oncology Clinics of North America
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
Francis LeBlanc, Zainul S. Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Violetta V. Leshchenko, Samir Sunil Parekh, Haiqing Fu, Ya Zhang, Melvenia M. Martin et al. · 2022 · Oncotarget
Emerging pharmacology of targeted protein degraders
Samir H. Barghout, Mohamed A. Eldeeb · 2025 · Journal of Pharmacology and Experimental Therapeutics
Front-line therapy in elderly patients with mantle cell lymphoma
Victor Manuel Orellana-Noia, Johanna C. Kluin-Nelemans, Michael E. Williams · 2019 · Annals of Lymphoma
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
Malte Roerden, Stefan Wirths, Martin Sökler, Wolfgang Andreas Bethge, Wichard Vogel, Juliane S. Walz · 2021 · Cancers
Immunomodulatory agents in mantle cell lymphoma
Kieron M. Dunleavy · 2016 · The Lancet Oncology
What is the optimal initial management of the younger mantle cell lymphoma patient?
Rory McCulloch, Simon A. Rule · 2017 · Best Practice & Research Clinical Haematology
Pitfalls of Combining Novel Agents in Lymphoma
Thomas David Rodgers, Paul M. Barr · 2018 · Current Treatment Options in Oncology
Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma
Priyanka Avinash Pophali, Gita Thanarajasingam · 2020 · Hematology/Oncology Clinics of North America
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
Suning Chen, Weili Zhao, Jianyong Li, Depei Wu · 2022 · Frontiers of Medicine
Frontline treatment approaches in TP53-aberrant mantle cell lymphoma
Nikesh N. Shah, Franco Castillo Tokumori, Junmin Whiting, David C. Boulware, Jose David Sandoval-Sus, Todd Cory Knepper, Mohammad Hussaini, Jianguo Tao, Julio C. Chávez, Leidy Lismeri Isenalumhe et al. · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice
Elisa Santambrogio, Mattia Novo, Delia Rota‐Scalabrini, Umberto Vitolo · 2020 · Expert Review of Hematology
Novel therapies under investigation for mantle cell lymphoma
Tadeusz Robak · 2016 · Expert Opinion on Investigational Drugs
Personalized approaches for treatment-naïve mantle cell lymphoma
David Augustus Qualls, Anita Ashok Kumar · 2023 · Expert Review of Hematology
Emerging first-line treatment approaches for mantle cell lymphoma
Changchun Deng, Nikki Agarwal, Ariel D. Sindel · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
Chemotherapy-free induction in MCL: ready for prime time?
Kami J. Maddocks · 2018 · Blood
Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell Lymphoma
Thomas David Rodgers, Jonathan W. Friedberg · 2020 · Hematology/Oncology Clinics of North America
A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma
Baskaran Subramani, Patrick J. Conway, Aisha Al‐Khinji, Kun Zhang, Ritu Pandey, Daruka Mahadevan · 2024 · Cancers
Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case
Mian Ren, Luxi Cao, Quanquan Shen, Bin Zhu, Juan Wu · 2025 · Frontiers in Medicine
[The consensus of the diagnosis and treatment of mantle cell lymphoma in China (2016 version)].
2016 · PubMed Central
Chemotherapy-free treatment in non-Hodgkin lymphoma: a steep learning curve
Patrick Michael Reagan, Paul M. Barr · 2017 · The Lancet Haematology
Mantle Cell Lymphoma
Vijaya Raj Bhatt, Roberto Ferro Valdes, Julie Marie Vose · 2017 · Elsevier eBooks
Does maintenance therapy have a role in mantle cell lymphoma treatment?
Madeliene Parrott, Simon A. Rule · 2018 · Expert Review of Hematology
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma
Radhika Takiar, Tycel Jovelle Phillips · 2021 · Current Treatment Options in Oncology
Mantle Cell Lymphoma: Saudi Lymphoma Group’s Clinical Practice Guidelines for Diagnosis, Management and Follow-up
Musa Fares Alzahrani, Ahmed Sagheir, Ibraheem Motabi, Reyad Dada, Mubarak M. Al-Mansour, Hani Alhashmi, Magdy S. Kandil, Ayman Alhejazi · 2019 · Saudi Journal of Medicine and Medical Sciences
CAR-T therapy in mantle cell lymphoma: a review of the current literature
Joanna Romejko‐Jarosińska · 2022 · Acta Haematologica Polonica
Aktuelle Therapiestrategien beim Mantelzelllymphom
Martin H. Dreyling, Andrea Schnaiter, Christian Schmidt, Eva Hoster · 2016 · Der Internist
The Changing Landscape of Relapsed/ Refractory Non-Hodgkin Lymphoma
Natalie Galanina · 2016 · Journal of Blood Disorders and Medicine
Lenalidomide in chronic lymphocytic leukemia
Punit L. Jain, Carrie Anne Orlikowski, Alessandra Ferrajoli · 2016 · Expert Opinion on Orphan Drugs
Combined therapy in MCL: less may be more?
Martin H. Dreyling · 2016 · Blood
A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia
Emmanuelle Tavernier, Jérôme Cornillon, C. Molucon-Chabrot, Jean-Yves Y. Cahn, Fabien Tinquaut, Aurélie Bourmaud, Denis Guyotat, Xavier Thomas · 2016 · Hematology
Mantle cell lymphoma
Elizabeth Budde · 2017 · Springer eBooks